What the analyst said

Goldman Sachs analyst Gabriela Borges assumed coverage on Oracle (NYSE: ORCL) with a Buy rating (up from Neutral) and a price target of $240.00.

“We assume coverage on Oracle at Buy (from Neutral) with 27% upside to our 12 month price target of $240.

We are positive on Oracle’s technology advantage in AI compute workloads, and believe the company has the potential to gain share vs. the cloud cycle (backlog suggests ~25% share of new cloud revenue in 3 years from <10% today).

The question then becomes the timing and unit economics associated with the capex build to support backlog being recognized as revenue.

We are tactically positive on the stock as we believe visibility will improve over the next 12 months: 1) we expect revenue reacceleration over the course of this year as more tranches of the 1.2 GW Abilene data center come online; 2) we expect gross profit to trough in the next 12 months, followed by meaningful acceleration, based on our bottom up build of fixed and variable COGS; 3) we believe we are close to peak debt raises, as our build suggests Oracle can execute on its data center build with less than $80mn in debt raised (consistent with management comments of <$100bn), of which $18bn has already been raised and a further $38bn is already anticipated.

For Oracle to be an investment rather than a trade, we look to better gauge the sustainability of growth and pricing beyond 2030, as well as in its database and apps businesses (~30% of sales).

At $190, we believe the market is already discounting Oracle/Street forecasts of $20 in FY30 in EPS, and we see a scenario where gross margin is below the Street this year ahead of acceleration.

As such, we approach risk/reward for the stock by considering bear/base/bull scenarios that discounts OpenAI commitments by 100%/30%/0% to arrive at $10/$15/$25 of EPS or a 4:1 upside/downside skew when applying a 10x-25x range of P/E multiples.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

ORCL trades at $116. The 22 analysts who set a target in the last 3 months range from $155 to $400, with a median of $233. This $240 target is 3% above the median.

Since the note ORCL has moved −42% (from $199). 12-month window: day 299 of 365, closes on January 12, 2027.

Track record

This call✓ Target reached on June 1, 2026, 5 months after the note.

Firm track recordGoldman Sachs: 78% of its 37 targets at least a year old were reached within 12 months (#17 of 26 firms). Accuracy ranking →

Goldman Sachs on Oracle

Goldman Sachs price targets on Oracle

2 calls from January 12, 2026 to October 23, 2026. The target went from $240 to $206 (−14%). The rating stayed Buy.

Goldman Sachs targetORCL share price
  1. October 23, 2026Target cut from $240 (−14%)Buy$206
  2. January 12, 2026 This noteEarliest call shownBuy$240
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.